Qualcomm Incorporated ( QCOM ) shares are experiencing a decline Monday after reports surfaced about the company’s interest in acquiring Intel Corporation ( INTC ) . Here’s what you need to know.

What To Know: The news highlights Qualcomm’s potential strategic move to bolster its product line and diversify its business through a multi-billion dollar acquisition of Intel ( INTC ). At the same time, Apollo Global Management ( APO ) has proposed a significant investment in Intel ( INTC ).

The Qualcomm-Intel deal, if it materializes, would mark one of the largest mergers in the semiconductor industry, potentially surpassing Microsoft’s $69 billion acquisition of Activision Blizzard. However, analysts have raised concerns about the financial and regulatory hurdles Qualcomm ( QCOM ) could face.

Recap:

Qualcomm’s Potential Acquisition of Intel ( INTC ): Reports indicate that Qualcomm ( QCOM ), led by CEO Cristiano Amon, is considering acquiring Intel ( INTC ) as part of its broader efforts to diversify. The deal would involve merging two of the world's major chipmakers, impacting sectors such as smartphones, PCs and servers. However, industry analysts believe that Qualcomm ( QCOM ) will face significant antitrust scrutiny, especially given the size and scale of both companies.

Apollo Global's $5 Billion Investment Offer: Separately, Apollo Global Management ( APO ) has proposed a $5 billion investment in Intel ( INTC ). Apollo and Intel ( INTC ) already have a working relationship after Apollo's $11 billion deal earlier this year to acquire a stake in an Intel ( INTC ) venture in Ireland.

Intel's ( INTC ) Struggles and Recent Developments: Intel ( INTC ) has been facing one of its most challenging periods in decades, with its market value dropping below $100 billion. The company reported dismal second-quarter earnings, which saw an 84% drop compared to the previous year.

QCOM Price Action: Qualcomm’s shares dropped by 1.37%, currently trading at $166.61 according to Benzinga Pro.

See Also:

Assembly Biosciences’ Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants

Image Via Shutterstock.